24322 Federal Register / Vol. 72, No. 84 / Wednesday, May 2, 2007 / Notices 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental & Craniofacial Research Special 

Emphasis Panel; 07–48, Review R25s. 

Date: June 5, 2007. 

Time: 2 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892 (Telephone Conference Call). 

Contact Person: Sooyoun (Sonia) Kim, MS, 

45 Center Dr, 4An 32B, Division of 

Extramural Research, National Inst. of Dental 

& Craniofacial Research, National Institutes 

of Health, Bethesda, MD 20892, (301) 594– 

4827, kims@email.nidr.nih.gov. 

Name of Committee: National Institute of 

Dental & Craniofacial Research Special 

Emphasis Panel; 07–51, Review R21s PAR– 

06–556. 

Date: June 6, 2007. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892 (Telephone Conference Call). 

Contact Person: Lynn M. King, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, 45 Center Dr., Rm 4AN–32F, 

National Inst of Dental & Craniofacial 

Research, National Institutes of Health, 

Bethesda, MD 20892–6402, 301–594–5006, 

lynn.king@nih.gov. 

Name of Committee: National Institute of 

Dental & Craniofacial Research Special 

Emphasis Panel; 07–52, Review R21s. 

Date: June 11, 2007. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892 (Telephone Conference Call). 

Contact Person: Lynn M. King, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, 45 Center Dr., Rm 4AN–32F, 

National Inst of Dental & Craniofacial 

Research, National Institutes of Health, 

Bethesda, MD 20892–6402, 301–594–5006, 

lynn.king@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: April 25, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2149 Filed 5–1–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Digestive Diseases 

Core Centers. 

Date: June 15, 2007. 

Time: 8 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Renaissance Mayflower Hotel, 1127 

Connecticut Avenue, NW., Washington, DC 

20036. 

Contact Person: Maria E. Davila-Bloom, 

PhD, Scientific Review Administrator, 

Review Branch, DEA, NIDDK, National 

Institutes of Health, Room 758, 6707 

Democracy Boulevard, Bethesda, MD 20892– 

5452, (301) 594–7637, davilabloomm@extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: April 25, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2150 Filed 5–1–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Hematopoietic Cell 

Transportation and Immune Tolerance. 

Date: May 29, 2007. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Room 3136, Bethesda, MD 20817 (Telephone 

Conference Call). 

Contact Person: Mercy R. Prabhudas, PhD, 

Scientific Review Administrator, Scientific 

Review Program, Division of Extramural 

Activities, NIAID/NIH/DHHS, 6700B 

Rockledge Drive, MSC 7616, Bethesda, MD 

20892–7616, 301–451–2615, 

mp547nh@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS). 

Dated: April 25, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2151 Filed 5–1–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Public Teleconference Regarding 

Licensing and Collaborative Research 

Opportunities for: Use of CYP1B1*3 

Genotyping To Predict Overall Survival 

in Patients With Prostate Cancer Prior 

to Treatment With Docetaxel; Dr. 

William D. Figg et al. (NCI) 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

Technology Summary 

The technology is an exciting 

discovery in the field of prostate, breast 

and lung cancer genetic markers having 

profound clinical applications in 

defining the optimal chemotherapeutic 

mmaher on DSK3CLS3C1PROD with $$_JOB